Nihon Kohden Corporation Stock

Equities

6849

JP3706800004

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange 02:00:00 2024-05-20 am EDT 5-day change 1st Jan Change
4,474 JPY +2.12% Intraday chart for Nihon Kohden Corporation +3.40% +0.25%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 222B 1.43B Sales 2025 * 230B 1.48B Capitalization 368B 2.36B
Net income 2024 17.03B 109M Net income 2025 * 16.31B 105M EV / Sales 2024 1.51 x
Net cash position 2024 * 56.11B 360M Net cash position 2025 * 41.42B 266M EV / Sales 2025 * 1.42 x
P/E ratio 2024
19.8 x
P/E ratio 2025 *
23 x
Employees 5,751
Yield 2024
1.52%
Yield 2025 *
1.34%
Free-Float 94.59%
More Fundamentals * Assessed data
Dynamic Chart
Nihon Kohden Corporation announces an Equity Buyback for 6,000,000 shares, for ¥10,000 million. CI
Nihon Kohden Corporation authorizes a Buyback Plan. CI
Japanese Shares End in Green as Yen Weakens MT
Nihon Kohden to Book Extraordinary Gains of 4 Billion Yen in Fiscal Q4 Following Adjustment in Retirement Plan MT
Nihon Kohden Repurchases 1.1 Billion Yen Worth of Shares MT
Tranche Update on Nihon Kohden Corporation's Equity Buyback Plan announced on February 2, 2024. CI
Nihon Kohden Corporation's Equity Buyback announced on February 2, 2024, has closed with 250,000 shares, representing 0.3% for ¥1,123.75 million. CI
Nihon Kohden Corporation announces an Equity Buyback for 250,000 shares, representing 0.3% for ¥1,123.75 million. CI
Nihon Kohden Corporation authorizes a Buyback Plan. CI
Nihon Kohden Corporation Sets New Standard for Central Nursing with the Launch of CNS-2101 CI
Nihon Kohden Corporation Provides Final Dividend Guidance for the Fiscal Year Ending March 31, 2024 CI
Nihon Kohden Corporation Announces Interim Second Quarter Dividend for the Fiscal Year Ending March 31, 2024 CI
Nihon Kohden Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Nihon Kohden Corp Revises Forecast for Fiscal H1 Upwards to Reflect Stronger Sales, Weaker-than-Expected Yen MT
Nihon Kohden Corporation Revises Consolidated Earnings Guidance for the First Half Ended September 30, 2023 CI
More news
1 day+2.12%
1 week+2.83%
Current month+4.05%
1 month+6.91%
3 months+7.83%
6 months+21.35%
Current year+0.25%
More quotes
1 week
4 205.00
Extreme 4205
4 612.00
1 month
4 170.00
Extreme 4170
4 612.00
Current year
3 810.00
Extreme 3810
4 783.00
1 year
3 372.00
Extreme 3372
4 783.00
3 years
2 762.00
Extreme 2762
4 783.00
5 years
2 556.00
Extreme 2556
4 783.00
10 years
1 914.00
Extreme 1914
4 783.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 95-03-31
Chief Tech/Sci/R&D Officer - 84-03-31
Chief Administrative Officer 64 14-03-31
Members of the board TitleAgeSince
Director/Board Member 72 16-05-31
Director/Board Member 71 22-05-31
Director/Board Member 61 85-03-31
More insiders
Date Price Change Volume
24-05-20 4,474 +2.12% 291 200
24-05-17 4,381 +0.48% 228,100
24-05-16 4,360 +3.56% 232,200
24-05-15 4,210 -4.84% 243,000
24-05-14 4,424 +1.68% 489,600

Delayed Quote Japan Exchange, May 20, 2024 at 02:00 am EDT

More quotes
NIHON KOHDEN CORPORATION is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company mainly operates medical electronics related business. The Company offers electroencephalograph, electromyographic, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
4,381 JPY
Average target price
4,665 JPY
Spread / Average Target
+6.48%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW